Cargando…
Pseudomyxoma Peritonei: A Need to Establish Evidence-Based Standard of Care—Is This the Right Trial?
Autores principales: | Chua, Terence C., Al-Mohaimeed, Khaled, Liauw, Winston, Morris, David L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749180/ https://www.ncbi.nlm.nih.gov/pubmed/19639367 http://dx.doi.org/10.1245/s10434-009-0550-1 |
Ejemplares similares
-
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
por: Bjersand, Kathrine, et al.
Publicado: (2015) -
Pseudomyxoma Peritonei
por: Homeag, Maria, et al.
Publicado: (2009) -
Quality of Life Study following Cytoreductive Surgery and Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei including Redo Procedures
por: Kirby, Rachel, et al.
Publicado: (2013) -
Physical and chemical characteristics of mucin secreted by pseudomyxoma peritonei (PMP)
por: Pillai, Krishna, et al.
Publicado: (2017) -
Case of intraperitoneal sepsis secondary to rupture of the appendix on the background of pseudomyxoma peritonei
por: Huang, Y., et al.
Publicado: (2014)